Cibc Asset Management Inc Legend Biotech Corp Transaction History
Cibc Asset Management Inc
- $28 Billion
- Q4 2024
A detailed history of Cibc Asset Management Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Cibc Asset Management Inc holds 6,698 shares of LEGN stock, worth $253,720. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,698
Previous 6,549
2.28%
Holding current value
$253,720
Previous $319,000
31.97%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LEGN
# of Institutions
233Shares Held
86.1MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$284 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$258 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$227 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$217 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$216 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.34B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...